Abstract
Both crude and highly purified testicular hyaluronidase preparations have been shown to contain a component which increases the permeability of the microcirculation in rat skin. This permeability activity had an isoelectric point of 7.4 while hyaluronidase was 9.4. It also could be separated from hyaluronidase by acrylamide gel electrophoresis. The permeability factor was not inhibited by serum and may explain previous observations that hyaluronidase preparations decrease the ischemia and necrosis appropriate to experimental myocardial infarction in vivo.
Similar content being viewed by others
References
MacLean, D., M. Fishbein, P. Maroko, andE. Braunwald. 1976. Hyaluronidase-induced reductions in myocardial infarct size.Science 194:199.
Hadidian, Z., andN. Pirie. 1948. The effects of serum and of hyaluronic acid derivatives on the action of hyaluronidase.Biochem. J. 42:266.
Wattenburg, L., andD. Glick. 1952. Mucolytic enzyme systems; purification of nonspecific hyaluronidase inhibitor in human blood.Arch. Biochem. 35:290.
Good, T., R. Good, V. Kelley, andD. Glick. 1951. Mucolytic enzyme systems; factors influencing hyaluronidase inhibitor levels in serum, role of adrenal cortex.Am. J. Physiol 166:555.
Lykke, A., P. Willoughby, andJ. Houck. 1967. Effects of cortisol released cutaneous protease upon the permeability of the micro-circulation.J. Invest. Dermatol. 48:318.
Pearce, R. H. 1953. The turbidimetric estimation of hyaluronate.Biochem. J. 55:472.
Davis, B. 1964. Disc electrophoresis. II Method and application to human serum proteins.Ann. N.Y. Acad. Sci. 121:404.
Vesterberg, O., andH. Svenson. 1966. Isoelectric fractionation analysis and characterization of ampholytes in natural pH gradients.Acta Chem. Scand. 20:820.
Umezawa, H., T. Aoyagi, H. Morishima, M. Matsuyaki, H. Hamada, andT. Takenshi. 1970. Pepstatin, a new pepsin inhibitor produced by actinomycetes.Antiobiotics 23:259.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Houck, J.C., Chang, C.M. Permeability factor contaminating hyaluronidase preparations. Inflammation 3, 447–451 (1979). https://doi.org/10.1007/BF00913502
Issue Date:
DOI: https://doi.org/10.1007/BF00913502